Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-04-06
DOI
10.3389/fphar.2017.00191
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serotonergic Modulation as Effective Treatment for Dravet Syndrome in a Zebrafish Mutant Model
- (2016) Jo Sourbron et al. ACS Chemical Neuroscience
- Brain-wide mapping of neural activity controlling zebrafish exploratory locomotion
- (2016) Timothy W Dunn et al. eLife
- Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children
- (2016) Zhongliang Du et al. MEDICAL SCIENCE MONITOR
- Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs
- (2016) Dubravka Svob Strac et al. Frontiers in Neuroscience
- Huperzine A Provides Robust and Sustained Protection against Induced Seizures in Scn1a Mutant Mice
- (2016) Jennifer C. Wong et al. Frontiers in Pharmacology
- Allosteric modulation of sigma-1 receptors elicits anti-seizure activities
- (2015) Lin Guo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sigma receptors [σRs]: biology in normal and diseased states
- (2015) Colin G. Rousseaux et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Epilepsy: new advances
- (2015) Solomon L Moshé et al. LANCET
- Live imaging reveals a new role for the sigma-1 (σ1) receptor in allowing microglia to leave brain injuries
- (2015) Christian Moritz et al. NEUROSCIENCE LETTERS
- Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome
- (2015) An-Sofie Schoonjans et al. Therapeutic Advances in Neurological Disorders
- Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine
- (2015) Yifan Zhang et al. PLoS One
- Synthesis and Structure–Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2C Agonists
- (2014) Martin Hansen et al. ACS Chemical Neuroscience
- Activation of 5-HT2C Receptor Promotes the Expression of Neprilysin in U251 Human Glioma Cells
- (2014) Xiao-Lu Tian et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- A pilot double-blind trial using verapamil as adjuvant therapy for refractory seizures
- (2014) Felippe Borlot et al. EPILEPSY RESEARCH
- A Comprehensive Ligand Based Mapping of the σ2 Receptor Binding Pocket
- (2014) Derek Rhoades et al. Medicinal Chemistry
- Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes
- (2014) Julian Schubert et al. NATURE GENETICS
- Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice
- (2014) Akshitkumar M. Mistry et al. NEUROBIOLOGY OF DISEASE
- De Novo Loss-of-Function Mutations in CHD2 Cause a Fever-Sensitive Myoclonic Epileptic Encephalopathy Sharing Features with Dravet Syndrome
- (2013) Arvid Suls et al. AMERICAN JOURNAL OF HUMAN GENETICS
- New onset hypertension following abrupt discontinuation of citalopram
- (2013) Walter J. Astorne Figari et al. CLINICAL NEPHROLOGY
- Peripheral 5-HT1D and 5-HT7 serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats
- (2013) José Ángel García-Pedraza et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The zebrafish reference genome sequence and its relationship to the human genome
- (2013) Kerstin Howe et al. NATURE
- New avenues for anti-epileptic drug discovery and development
- (2013) Wolfgang Löscher et al. NATURE REVIEWS DRUG DISCOVERY
- Epilepsy in kcnj10 Morphant Zebrafish Assessed with a Novel Method for Long-Term EEG Recordings
- (2013) Anselm A. Zdebik et al. PLoS One
- Efficacy of verapamil as an adjunctive treatment in children with drug-resistant epilepsy: A pilot study
- (2013) Francesco Nicita et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- The role of different serotonin receptor subtypes in seizure susceptibility
- (2013) Mohammad Hadi Gharedaghi et al. EXPERIMENTAL BRAIN RESEARCH
- Successful use of fenfluramine as an add-on treatment for Dravet syndrome
- (2012) Berten Ceulemans et al. EPILEPSIA
- Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibility
- (2012) Stacey B. Dutton et al. NEUROBIOLOGY OF DISEASE
- The core Dravet syndrome phenotype
- (2011) Charlotte Dravet EPILEPSIA
- Molecular biology of epilepsy genes
- (2011) Charles A. Williams et al. EXPERIMENTAL NEUROLOGY
- Does Dravet Syndrome Have a Recognizable Face?
- (2011) Kathleen J. Nolan et al. PEDIATRIC NEUROLOGY
- Genes of Early-Onset Epileptic Encephalopathies: From Genotype to Phenotype
- (2011) Mario Mastrangelo et al. PEDIATRIC NEUROLOGY
- Zebrafish: An in vivo model for the study of neurological diseases
- (2011) Jonathan Best Neuropsychiatric Disease and Treatment
- Optogenetic Localization and Genetic Perturbation of Saccade-Generating Neurons in Zebrafish
- (2010) P. J. Schoonheim et al. JOURNAL OF NEUROSCIENCE
- Is elevated norepinephrine an etiological factor in some cases of epilepsy?
- (2010) Paul J. Fitzgerald SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Zebrafish β-adrenergic receptor mRNA expression and control of pigmentation
- (2009) Zhipeng Wang et al. GENE
- β 2 -Adrenoceptor Antagonist ICI 118,551 Decreases Pulmonary Vascular Tone in Mice via a G i/o Protein/Nitric Oxide-Coupled Pathway
- (2009) Daniela Wenzel et al. HYPERTENSION
- Designing Selective, High Affinity Ligands of 5-HT1DReceptor by Covalent Dimerization of 5-HT1FLigands Derived From 4-Fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide
- (2008) Seok-Ki Choi et al. JOURNAL OF MEDICINAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started